| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972729 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
Both CRP and insulin resistance, as estimated by TG/HDL, appear to be strong, synergic risk factors for CAV and for major cardiac adverse events. These findings support the hypothesis that in heart transplant recipients, systemic inflammation may be an important mediator of graft vascular injury associated with metabolic syndrome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ombretta MD, Luciano MD, PhD, William F. MD, Helen I. RN, MS, Alan MD, Rossella MD, Sharon A. MD, Edward S. PhD, Hannah A. MD, MRCP, FACC,